Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?

Author： Tegeder Irmgard Geisslinger Gerd

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.373, Iss.1, 2006-04, pp. : 1-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effects of Specific Cyclooxygenase-2 Inhibitors on Carcinogenesis

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 291-295

Bentham Science Publishers

Access to resources Recommend Favorite

Gender Differences in Body Consciousness and Substance Use Among High-Risk Adolescents

By Black David Scott Sussman Steve Unger Jennifer Pokhrel Pallav Sun Ping

Substance Use & Misuse, Vol. 45, Iss. 10, 2010-06 ,pp. : 1623-1635

Informa Healthcare

Access to resources Recommend Favorite

Selective inhibitors of cyclooxygenase-2

By Talley J.J.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 1, 1997-01 ,pp. : 55-62

Informa Healthcare

Access to resources Recommend Favorite

Biological and Anti-inflammatory Evaluation of Two Thiazole Compounds in RAW Cell Line: Potential Cyclooxygenase-2 Specific Inhibitors

Medicinal Chemistry, Vol. 8, Iss. 3, 2012-05 ,pp. : 401-408

Bentham Science Publishers

Access to resources Recommend Favorite

Sex Differences in Type-2 Diabetes: Implications for Cardiovascular Risk Management

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1471-1476

Bentham Science Publishers

Access to resources Recommend Favorite